Outcomes of Women Who Were Premenopausal at Diagnosis in the MA17 Trial of Extended Letrozole After Five Years of Tamoxifen

Effect of High-Dose Vitamin D Therapy on Bone Mineral Density and Anastrozole-Induced Musculoskeletal Pain

Oral Bisphosphonates and Breast Cancer — Prospective Results from the Women’s Health Initiative (WHI)

Effect of Obesity on Prognosis After Early Breast Cancer

Cardiac Safety Results of a Docetaxel/Cyclophosphamide/Trastuzumab Combination in Patients with HER2-Positive Early-Stage Breast Cancer

Assessment of the Prognostic Role of HER2 Overexpression in Patients with Node-Negative, pT1a-b Breast Cancer

Updated Survival Analysis of the EGF104900 Randomized Study of Lapatinib Alone or Combined with Trastuzumab for HER2-Positive Breast Cancer Progressing on Trastuzumab

Molecular Characterization of Breast Cancer Core Biopsy Specimens by RT-PCR Gene Expression Analysis

Effect of a 21-Gene RT-PCR Assay on Treatment Recommendations for Patients with Node-Positive, ER-Positive Breast Cancer

Prognostic and Predictive Value of the 21-Gene Recurrence Score^® for Women with Node-Positive Breast Cancer Receiving Chemotherapy

Tyrosine Kinases as Targets for Cancer Therapy

Sunitinib versus Capecitabine for Patients with HER2-Negative Advanced Breast Cancer

SOLTI-0701 — A Double-Blind, Randomized Phase IIb Study of Capecitabine with or without Sorafenib in Advanced Breast Cancer

Double-Blind, Randomized Phase IIb Study of Paclitaxel with or without Sorafenib for Patients with HER2-Negative Advanced Breast Cancer

Analysis of the Incidence of Osteonecrosis of the Jaw and Surgical Complications with Neoadjuvant Therapy in Patients Receiving Bevacizumab